Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers
Clinical trial NCT02432664 · TERMINATED
Trial details
- NCT number
- NCT02432664
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-14
- Primary completion
- 2016-04-22
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.